The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant.
Anil, B., Riedinger, C., Endicott, J.A., Noble, M.E.(2013) Acta Crystallogr D Biol Crystallogr 69: 1358-1366
- PubMed: 23897459 
- DOI: 10.1107/S0907444913004459
- Primary Citation of Related Structures:  
4HFZ, 4HG7 - PubMed Abstract: 
The p53-binding site of MDM2 holds great promise as a target for therapeutic intervention in MDM2-amplified p53 wild-type forms of cancer. Despite the extensive validation of this strategy, there are relatively few crystallographically determined co- ...